The Cxcr3 antagonist Nbi-74330 attenuates atherosclerotic plaque formation in Ldl receptor deficient mice

被引：0
|
作者：
van Wanrooij, Eva J. [1 ]
De Jager, Saskia C. [1 ]
van Es, Thomas [1 ]
de Vos, Paula [1 ]
Birch, Helen L. [2 ]
Owen, David A. [2 ]
Watson, Robbert J. [2 ]
Biessen, Erik A. [1 ]
Chapman, Gayle A. [2 ]
van Berkel, Theo J. [1 ]
Kuiper, Johan [1 ]
机构：
[1] Leiden Univ, Leiden, Netherlands
[2] UCB, Cambridge, England
来源：
CIRCULATION | 2007年 / 116卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：171 / 172
页数：2
相关论文
共 50 条
  • [11] PLATELET INTEGRIN αIIBβ3 ANTAGONIST ATTENUATES ATHEROSCLEROTIC PLAQUE FORMATION AND PROGRESSION OF ATHEROSCLEROSIS IN APOE-DEFICIENT MICE ON A HIGH-FAT DIET
    Zhu, Jie
    Nie, Yumei
    Zhou, Birong
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 114 - 115
  • [12] Xyloketal B Attenuates Atherosclerotic Plaque Formation and Endothelial Dysfunction in Apolipoprotein E Deficient Mice
    Zhao, Li-Yan
    Li, Jie
    Yuan, Feng
    Li, Mei
    Zhang, Quan
    Huang, Yun-Ying
    Pang, Ji-Yan
    Zhang, Bin
    Sun, Fang-Yun
    Sun, Hong-Shuo
    Li, Qian
    Cao, Lu
    Xie, Yu
    Lin, Yong-Cheng
    Liu, Jie
    Tan, Hong-Mei
    Wang, Guan-Lei
    MARINE DRUGS, 2015, 13 (04): : 2306 - 2326
  • [13] Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice
    Yamada, Y.
    Okubo, Y.
    Shimada, A.
    Oikawa, Y.
    Yamada, S.
    Narumi, S.
    Matsushima, K.
    Itoh, H.
    DIABETOLOGIA, 2012, 55 (08) : 2238 - 2245
  • [14] Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice
    Y. Yamada
    Y. Okubo
    A. Shimada
    Y. Oikawa
    S. Yamada
    S. Narumi
    K. Matsushima
    H. Itoh
    Diabetologia, 2012, 55 : 2238 - 2245
  • [15] A CXCR2 antagonist, SB-332235, reduces atherosclerosis in LDL receptor deficient mice
    Benson, GM
    Grimsditch, DC
    Piercy, V
    Vidgeon-Hart, M
    Groot, PHE
    Suckling, K
    Sarau, HM
    Foley, JJ
    Jin, Q
    Palovich, M
    Widdowson, KL
    ATHEROSCLEROSIS, 2005, 181 (01) : S3 - S3
  • [16] The chemokine receptor CXCR3 is critical for the Alzheimer-like plaque formation in transgenic APP/PS1 mice
    Marius, Krauthausen
    Markus, Kummer
    Dick, Terwel
    Julian, Zimmermann
    Michael, Heneka
    Marcus, Muller
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 35 - 36
  • [17] Adiponectin protects against cardiac fibrosis but not the formation of atherosclerotic lesions in LDL receptor deficient mice
    Nawrocki, A. R.
    Hofmann, S. M.
    Teupser, D.
    Basford, J. E.
    Rickes, E. L.
    Tanowitz, H. B.
    Chang, C. H.
    Hui, D. Y.
    Scherer, P. E.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S63 - S63
  • [18] Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of LDL receptor-deficient mice
    Thorp, Edward
    Kurialkose, George
    Tabas, Ira
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E62 - E62
  • [19] Supplementation of diets with the black rice pigment fraction attenuates atherosclerotic plaque formation in apolipoprotein E deficient mice
    Xia, M
    Ling, WH
    Ma, J
    Kitts, DD
    Zawistowski, J
    JOURNAL OF NUTRITION, 2003, 133 (03): : 744 - 751
  • [20] The chemokine receptor CXCR3 attenuates the control of chronic Mycobacterium tuberculosis infection in BALB/c mice
    Chakravarty, Soumya D.
    Xu, Jiayong
    Lu, Bao
    Gerard, Craig
    Flynn, JoAnne
    Chan, John
    JOURNAL OF IMMUNOLOGY, 2007, 178 (03): : 1723 - 1735
12345